Nabila Waheed, DO
Radiation Oncology · Fort Worth, TXNPI 1700220183
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by GT Medical Technologies, Inc at 51.7% of the total. 2025 is the largest year on record at $2,835, 6.2 times the $455 reported in 2019.
Across 58 payments — averaging $86.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$3K
- Reflexion Medical, Inc.$600
- Carbofix Spine Inc$293
- Sirtex Medical Inc$258
- Johnson & Johnson$162
- Monteris Medical Corporation$135
- plus $978 from 25 others
What the payments were for
- Consulting fees$4008%
- Travel & lodging$1,65633%
- Food & beverage$2,93959%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 8 | $2,592 |
| Reflexion Medical, Inc. | 1 | $600 |
| Carbofix Spine Inc | 3 | $293 |
| Sirtex Medical Inc | 2 | $258 |
| Johnson & Johnson | 2 | $162 |
| Monteris Medical Corporation | 1 | $135 |
| E.r. Squibb & Sons, L.L.C. | 2 | $134 |
| Puma Biotechnology, Inc. | 1 | $125 |
| Novartis | 6 | $113 |
| Blue Earth Diagnostics | 3 | $59 |
| Progenics Pharmaceuticals, Inc. | 2 | $42 |
| Exelixis Inc. | 1 | $38 |
| Bayer | 2 | $36 |
| Incyte Corporation | 2 | $36 |
| Tersera Therapeutics LLC | 2 | $33 |
| Tactile Systems Technology Inc | 2 | $32 |
| AstraZeneca | 2 | $32 |
| Napo Pharmaceuticals Inc | 1 | $30 |
| Daiichi Sankyo Inc. | 2 | $29 |
| Boston Scientific | 2 | $28 |
| Sanofi | 1 | $25 |
| Bristol Myers Squibb | 1 | $25 |
| Teleflex LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| AbbVie | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $17 |
| Seagen Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GammaTile$2,592
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM$600
- SIR-Spheres Microspheres$258
- Erleada$147
- AKEEGA$147
- Neuroblate$135
- Nerlynx$125
- OPDIVO$122
How this compares
$5,018 in reported general payments places this provider in the 85th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 147 | $1,919 |
| SsdSilver Sulfadiazine | 22 | $804 |
| Dexamethasone | 96 | $797 |
| Silver Sulfadiazine | 17 | $572 |
| Tamsulosin Hcl | 24 | $113 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Fort Worth
- Matthew CaveyFort Worth$22K
- James WelshHouston$421K
- Stephen ChunHouston$344K
- Jim HsiangCorpus Christi$258K
- Chad TangHouston$183K
- Phuoc TranHouston$177K
- Hak ChoyDallas$119K
- Steven LinHouston$105K
- Benjamin SchrankHouston$100K
- Robert TimmermanDallas$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.